KIR2DL2 might alter NK cell antifibrotic function, with the release of cytotoxic substances promoting cell lysis and cytokine secretion, including IFN-γ, responsible for the inhibition of liver fibrosis (56). This evidence concerns the gene IFNG and Hepatic fibrosis.